1.Glycaemic, Blood Pressure and Low Density Lipoprotein Cholesterol Control in Adult Patients with Diabetes in Singapore: A Review of Singapore Literature Over Two Decades.
Zhongxian POH ; Kavita VENKATARAMAN ; Sue-Anne Es TOH ; Lian Leng LOW
Annals of the Academy of Medicine, Singapore 2017;46(10):374-391
INTRODUCTIONDiabetes mellitus is a burgeoning global health epidemic, with an estimated 422 million people living with diabetes in 2014. The number of adult diabetic patients in Singapore is expected to rise to 1 million in 2050. Despite advances made in the management of diabetes and improvements in healthcare accessibility and delivery, the rate and complications of diabetes (myocardial infarction, stroke, kidney failure and lower limb amputation) in Singapore have not decreased. Gaps between guidelines and practice have been reported in several parts of the world. In this narrative review, we aimed to describe the control of diabetes in Singapore over the past 20 years.
MATERIALS AND METHODSWe reviewed studies describing, or trials intervening in, the glycaemic, blood pressure (BP) and low density lipoprotein cholesterol (LDL-C) control of adult diabetic patients in Singapore published over the past 20 years (1997-2016). Studies selected from comprehensive electronic databases searches were reviewed by 4 reviewers (2 primary care physicians, 1 diabetologist and 1 public health epidemiologist). The GRADE approach was used to evaluate the quality of evidence.
RESULTSWe included 23 articles involving 257,097 subjects. There were 9 longitudinal, 12 cross-sectional and 2 case-control studies. All studies reported mean/median HbA1c between 7.2%-8.6%. BP ranged between 126.5-144 mmHg (systolic) and 70-84 mmHg (diastolic) in 9 studies. Nine studies reported LDL-C between 2.4-3.3 mmol/L.
CONCLUSIONMirroring global patterns, the glycaemic, BP and LDL-C control in adult diabetic patients in Singapore do not appear to be treated to target in the majority of patients.
2.Ministry of Health Clinical Practice Guidelines: Lipids.
E Shyong TAI ; Boon Lock CHIA ; Amber Carla BASTIAN ; Terrance CHUA ; Sally Chih Wei HO ; Teck Siew KOH ; Lip Ping LOW ; Jeannie S TEY ; Kian Keong POH ; Chee Eng TAN ; Peter TING ; Tat Yean THAM ; Sue-Anne TOH ; Rob M van DAM
Singapore medical journal 2017;58(3):155-166
The Ministry of Health (MOH) has updated the Clinical Practice Guidelines on Lipids to provide doctors and patients in Singapore with evidence-based treatment for lipids. This article reproduces the introduction and executive summary (with recommendations from the guidelines) from the MOH Clinical Practice Guidelines on Lipids, for the information of SMJ readers. Chapters and page numbers mentioned in the reproduced extract refer to the full text of the guidelines, which are available from the Ministry of Health website: http://www.moh.gov.sg/content/moh_web/healthprofessionalsportal/doctors/guidelines/cpg_medical.html.
Adult
;
Cardiovascular Diseases
;
complications
;
therapy
;
Child
;
Coronary Artery Disease
;
complications
;
therapy
;
Decision Support Systems, Clinical
;
Dyslipidemias
;
blood
;
complications
;
therapy
;
Evidence-Based Medicine
;
Female
;
Humans
;
Kidney Failure, Chronic
;
complications
;
therapy
;
Life Style
;
Lipids
;
blood
;
Lipoproteins, LDL
;
blood
;
Male
;
Practice Guidelines as Topic
;
Pregnancy
;
Pregnancy Complications
;
Risk Assessment
;
Risk Factors
;
Singapore